What is the appropriate Eliquis (apixaban) dose after surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Eliquis Dosing After Surgery

For VTE prophylaxis after major orthopedic surgery (hip or knee replacement), Eliquis should be dosed at 2.5 mg orally twice daily, starting 12 to 24 hours after surgery. 1

Specific Dosing by Surgery Type

Hip Replacement Surgery

  • Dose: 2.5 mg twice daily
  • Initiation: 12-24 hours post-surgery
  • Duration: 35 days (5 weeks) 2, 1
  • Evidence: Superior to enoxaparin with 1.4% vs 3.9% VTE rate (p<0.001), without increased bleeding 3, 4

Knee Replacement Surgery

  • Dose: 2.5 mg twice daily
  • Initiation: 12-24 hours post-surgery
  • Duration: 10-14 days (2 weeks) 2, 1
  • Evidence: Superior to enoxaparin 40mg daily (15.1% vs 24.4% VTE, p<0.0001) 3, 5

Resuming Therapeutic Anticoagulation After Surgery

If the patient was on Eliquis for another indication (atrial fibrillation, VTE treatment) and needs to resume therapeutic dosing:

Timing Algorithm

  1. Low bleeding risk procedures: Resume therapeutic dose 24 hours post-procedure once hemostasis achieved 2, 6
  2. High bleeding risk procedures: Resume therapeutic dose 48-72 hours post-procedure once hemostasis achieved 2, 6
  3. Bridging strategy: Use prophylactic LMWH/heparin starting ≥6 hours post-procedure, then transition to therapeutic Eliquis 12 hours after last prophylactic LMWH dose 2

Therapeutic Doses (Post-Surgery Resumption)

  • Atrial fibrillation: 5 mg twice daily (or 2.5 mg twice daily if ≥2 of: age ≥80, weight ≤60kg, creatinine ≥1.5 mg/dL) 1
  • VTE treatment: 10 mg twice daily for 7 days, then 5 mg twice daily 1
  • VTE secondary prevention: 2.5 mg twice daily 1

Critical Perioperative Considerations

Pre-operative Interruption

Eliquis must be stopped before elective surgery:

  • Low bleeding risk: Stop 24 hours before 1
  • Moderate-high bleeding risk: Stop 48 hours before 1
  • Very high bleeding risk (neurosurgery, neuraxial anesthesia): Stop up to 5 days before if CrCl <50 mL/min 2

Epidural Catheter Management

Do NOT give therapeutic-dose Eliquis with an epidural catheter in place. Use heparin for therapeutic anticoagulation until catheter removal is safe 2. This is a critical safety issue—therapeutic DOACs and epidural catheters are incompatible due to spinal hematoma risk.

Common Pitfalls to Avoid

  1. Starting too early: Initiating within 12 hours post-surgery increases bleeding risk without additional VTE benefit
  2. Wrong dose for indication: Using prophylactic dose (2.5 mg BID) when therapeutic dose needed for pre-existing indication
  3. Inadequate duration: Stopping prophylaxis at hospital discharge rather than completing full course (35 days hip, 10-14 days knee)
  4. Overlapping anticoagulants: When transitioning from LMWH to Eliquis, give first Eliquis dose 12 hours after last LMWH to avoid excessive anticoagulation 2
  5. Ignoring renal function: While the 2.5 mg BID prophylactic dose doesn't require adjustment, therapeutic dosing does require consideration of CrCl 2

Special Populations

Bariatric Surgery

Recent evidence supports 2.5 mg twice daily for 30 days post-bariatric surgery, with favorable safety profile and no observed VTE events 7, 8. This represents an emerging indication with growing real-world data.

Renal Impairment

The prophylactic 2.5 mg twice daily dose does not require adjustment even with moderate renal impairment (CrCl >30 mL/min) 2. However, monitor renal function postoperatively as surgical stress may worsen kidney function and affect drug clearance 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.